Noticias de HIMS_US
Noticias del mercado
Últimas noticias sobre HIMS_US — 694 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst
Hims & Hers expands integrated health access via platform expansion
Hims & Hers Health, Inc. (HIMS) cerró el día de negociación más reciente a 31,89 dólares, un +1,33% con respecto a la sesión de negociación anterior.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect
Hims & Hers Health Inc (HIMS) Stock Up 4.3% and Still Undervalued -- GF Score: 81/100
Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides Market
Página 33 de 35